Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE ROLE OF BLEEDING HISTORY AND CLINICAL MARKERS FOR THE CORRECT DIAGNOSIS OF VWD

    Alberto Tosetto
    e2013051
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.051
    2317
    PDF: 885
    HTML: 4025
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2538
    PDF: 1144
    HTML: 97
  • MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

    Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati
    e2016049
    2016-10-17
    https://doi.org/10.4084/mjhid.2016.049
    3280
    PDF: 702
    HTML: 702
    Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 168
    Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 163
    Table : Distribution of the sites of bleeding and their causes: 169
  • PATIENTS REFERRED FOR BLEEDING SYMPTOMS OF UNKNOWN CAUSE: DOES EVALUATION OF THROMBIN GENERATION CONTRIBUTE TO DIAGNOSIS?

    Elena Holm, Eva Zetterberg, Susanna Lövdahl, Erik Berntorp
    e2016014
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.014
    3694
    PDF: 779
    HTML: 1579
  • CIRCUMCISION IN MALES WITH BLEEDING DISORDERS

    Hassan Mansouritorghabeh, Abdollah Banihashem, Alireza Modaresi, Lida Manavifar
    e2013004
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.004
    1865
    PDF: 872
    HTML: 6751
    Cover letter: 151
  • NEGATIVE IMPACT OF PROLONGED ANTIBIOTICS OR PERSISTENT DIARRHEA ON VITAMIN K1 LEVELS IN 2-24 WEEKS AGED EGYPTIAN INFANTS

    Mohsen Elalfy, Fatma S E Ebeid, Iman Elagouza, Fatma Ibrahim, Noura Hassan, Beshoy Botros
    e2018010
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.010
    4204
    PDF: 811
    HTML: 956
  • CLINICAL PROFILE OF PATIENTS WITH RARE INHERITED COAGULATION DISORDERS: A RETROSPECTIVE ANALYSIS OF 67 PATIENTS FROM NORTHERN INDIA

    Sanjeev Kumar Sharma, Suman Kumar, Tulika Seth, Pravas Mishra, Narendra Agrawal, Gurmeet Singh, Avinash Singh, Manoranjan Mahapatra, Seema Tyagi, Haraprasad Pati, Renu Saxena
    e2012057
    2012-10-02
    https://doi.org/10.4084/mjhid.2012.057
    1274
    PDF: 537
    HTML: 2901
  • CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

    Giancarlo Castaman
    e2013052
    2013-07-16
    https://doi.org/10.4084/mjhid.2013.052
    2997
    PDF: 1017
    HTML: 8523
  • SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

    Galila F Zaher, Soheir S Adam
    e2012021
    2012-04-02
    https://doi.org/10.4084/mjhid.2012.021
    1248
    PDF: 879
    HTML: 3578
  • REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

    Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah
    e2021017
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.017
    1520
    PDF: 509
    HTML: 289
  • VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

    Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
    e2009033
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.033
    2569
    PDF: 492
    HTML: 3441
  • EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS

    Marta E Martinuzzo
    e2016037
    2016-08-16
    https://doi.org/10.4084/mjhid.2016.037
    3104
    PDF: 940
    HTML: 1882
    Untitled: 153
    Untitled: 158
    Untitled: 153
    Untitled: 155
    Untitled: 148
  • SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

    Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2024020
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.020
    1025
    PDF: 1206
    HTML: 88
  • PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

    Anna Falanga, Laura Russo, Carmen J Tartari
    e2011068
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.068
    1761
    PDF: 785
    HTML: 10211
    Figures 1,2,3: 157
  • DESCRIPTIVE EPIDEMIOLOGY OF HEMOPHILIA AND OTHER COAGULATION DISORDERS IN MANSOURA , EGYPT

    Youssef Al Tonbary, Rasha ElAshry, Maysaa El Sayed Zaki
    e2010025
    2010-08-03
    https://doi.org/10.4084/mjhid.2010.025
    1611
    PDF: 885
    HTML: 929
  • SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

    Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
    e2024006
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.006
    1095
    PDF: 1268
    HTML: 162
  • VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS

    Anna M. Randi, Mike A Laffan, Richard D. Starke
    e2013060
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.060
    3678
    PDF: 1530
    HTML: 8009
    Randi Fig: 163
  • CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY

    Vishal Vishnu Tewari, Kunal Tewari, Ritu Mehta
    e2018021
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.021
    4095
    PDF: 1707
    HTML: 464
    Figure 1: Age distribution of Pediatric cases: 201
  • Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

    Bhavya S Doshi, Valder R Arruda, Valder R Arruda
    e2020069
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.069
    1984
    PDF: 1833
    HTML: 332
  • MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS

    Lucio Amitrano, Maria Anna Guardascione
    e2009014
    https://doi.org/10.4084/mjhid.2009.014
    796
    PDF: 528
    HTML: 4005
  • RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC

    Rawanda Shamoon, Ahmed K. Yassin, Sara L. Alnuaimi
    e2024019
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.019
    990
    PDF: 1125
    HTML: 67
  • ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY

    Tekin Aksu
    e2018045
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.045
    2682
    PDF: 1227
    HTML: 578
  • Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

    Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini
    e2024047
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.047
    1127
    PDF: 961
    HTML: 76
  • CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

    Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan
    e2011060
    2011-12-07
    https://doi.org/10.4084/mjhid.2011.060
    2981
    PDF: 907
    HTML: 2281
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2750
    PDF: 1093
    HTML: 11207
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    2979
    PDF: 1345
    HTML: 521
  • VON WILLEBRAND FACTOR ABNORMALITIES STUDIED IN THE MOUSE MODEL: WHAT WE LEARNED ABOUT VWF FUNCTIONS

    Caterina Casari, Cecile V Denis
    e2013047
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.047
    2135
    PDF: 940
    HTML: 9568
  • ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

    chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi
    e2019066
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.066
    1331
    PDF: 862
    HTML: 1768
  • FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL

    Muhammad Imran Hasan Khan, Eram Anwar, Adnan Agha, Noha Saleh, Ehsan Ullah, Imran Ali Syed, Arsalan Raja
    e2013014
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.014
    2370
    HTML: 9378
    DOCX: 981
    Tables Dengue: 192
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2363
    PDF: 892
    HTML: 490
  • Acquired Hemophilia A successfully treated with rituximab

    Giovanni D'Arena, Elvira Grandone, Matteo Nicola Dario Di Minno, Pellegrino Musto, Giovanni Di Minno
    e2015024
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.024
    1868
    PDF: 1105
    HTML: 1444
    Figure 1: 156
  • DISCOVERY OF TYPE 3 VON WILLEBRAND DISEASE IN A COHORT OF PATIENTS WITH SUSPECTED HEMOPHILIA A IN CÔTE D’IVOIRE

    Adia Eusèbe Adjambri, Sylvie Bouvier, Roseline N'guessan, Emma N’draman-Donou, Mireille Yayo-Ayé, Marie-France Meledje, Missa Louis Adjé, Duni Sawadogo
    e2020019
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.019
    1410
    PDF: 1236
    HTML: 222
  • ACQUIRED REFRACTORY IRON DEFICIENCY

    Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta
    e2021028
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.028
    2719
    PDF: 1015
    HTML: 732
  • MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER

    Paola Ranalli, Stefano Baldoni, Daniela Bruno, Mauro Di Ianni
    e2024067
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.067
    1076
    PDF: 611
    Html: 139
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    609
    PDF: 356
    HTML: 64
  • Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

    Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith
    e2017034
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.034
    2604
    PDF: 1011
    HTML: 1155
  • Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia

    Alhossain A. Khalafallah, Zafreen Rahman, Kath Ogden, Terry Hannan
    e2012003
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.003
    1302
    PDF: 787
    HTML: 1005
    Untitled: 170
  • THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

    Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt
    e2017019
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.019
    4001
    PDF: 1888
    HTML: 1749
  • HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

    Armando Tripodi
    e2024027
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.027
    968
    PDF: 1310
    HTML: 110
  • Clinical Profile of Dengue Infection in Patients with Hematological Diseases

    Sanjeev Kumar Sharma, Tulika Seth, Pravas Mishra, Nitin Gupta, Narendra Agrawal, Shobha Broor, Manoranjan Mahapatra, Renu Saxena
    e2011039
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.039
    1561
    PDF: 753
    HTML: 1736
  • CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

    Vincenzo De Sanctis
    e2020032
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.032
    2089
    PDF: 1389
    HTML: 683
  • Massive pulmonary embolism at the onset of acute promyelocytic leukemia

    Federica Sorà, Patrizia Chiusolo, Luca Laurenti
    e2016027
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.027
    3440
    PDF: 857
    HTML: 1634
    figure 1: 151
    Untitled: 176
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2636
    PDF: 3130
    HTML: 334
  • NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY

    Francesco Rodeghiero, Dr. Mariasanta Napolitano, Nicola Vianelli, Lisanna Ghiotto, Silvia Cantoni, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Ugo Consoli, Gaetano Giuffrida, Elisa Lucchini, Elena Rossi, Cristina Santoro
    e2023019
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.019
    1827
    PDF: 1161
    PDF Appendix: 410
    HTML: 388
  • Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.

    Francesco Autore, Patrizia Chiusolo, Federica Sora', Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica
    e2023009
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.009
    1032
    PDF: 1036
    HTML: 424
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4256
    PDF: 1452
    HTML: 3604
  • PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta

    Mohamed Emara, Middle name: Hussien, Dr, Middle name: Asem, Dr, Prof., Prof., Dr.
    Page e2021033
    2021-04-29
    https://doi.org/10.4084/mjhid.2021.033
    1415
    PDF: 452
    MP4: 389
    Html: 179
  • BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

    Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini
    e2025076
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.076
    353
    PDF: 162
    Html: 37
  • Direct oral anticoagulants (DOACs) in the onco-hematologic patients

    Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2025022
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.022
    970
    PDF: 955
    HTML: 87
  • Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging

    Pier Mannuccio Mannucci
    e2019056
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.056
    1622
    PDF: 1415
    HTML: 235
1 - 50 of 183 items 1 2 3 4 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy